Wound dressings as growth factor delivery platforms for chronic wound healing

References

• Zhao A, Qin H, Fu X. What determines the regenerative capacity in animals? BioSci. 2016;66(9):735–746.
   Web of Science ®Google Scholar
• Iismaa SE, Kaidonis X, Nicks AM, et al. Comparative regenerative mechanisms across different mammalian tissues. Npj Regener Med. 2018;3:6.
   PubMed Web of Science ®Google Scholar
• Lorenz HP, Longaker MT, Perkocha LA, et al. Scarless wound repair: a human fetal skin model. Dev. 1992;114(1):253–259. Jan.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nat. 2008 May 15;453(7193):314–321.
   Web of Science ®Google Scholar
• Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014 Dec 3;6:(265)265sr6.
   PubMed Web of Science ®Google Scholar
• Pugliese E, Coentro JQ, Raghunath M, et al. Wound healing and scar wars. Adv Drug Deliv Rev. 2018 Apr;129:1–3.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4(8):583–594. Aug.
   PubMed Web of Science ®Google Scholar
• Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37(5):1528–1542. Sep-Oct.
   PubMed Web of Science ®Google Scholar
• Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219–1222. May.
   PubMed Web of Science ®Google Scholar
• Xue M, Zhao R, Lin H, et al. Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns. Adv Drug Deliv Rev. Apr 2018;129:219–241. .
   PubMed Web of Science ®Google Scholar
• Catanzano O, Boateng J. Local delivery of growth factors using wound dressings. In: Boateng J, editor. Therapeutic dressings and wound healing applications. USA: Wiley. 2020. p. 291–314. 2020/03/02.
   Google Scholar
• Dubay DA, Franz MG. Acute wound healing: the biology of acute wound failure. Surg Clin North Am. 2003;83(3):463–481. Jun. .
   PubMed Web of Science ®Google Scholar
• Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2(3):165–170. Jul.
   PubMedGoogle Scholar
• Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. 2017/06/15.
   PubMed Web of Science ®Google Scholar
• Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review. Rev Endocr Metab Disord. 2019;20(2):207–217. 2019/06/01.
   PubMed Web of Science ®Google Scholar
• Lindley LE, Stojadinovic O, Pastar I, et al. Biology and biomarkers for wound healing. Plast Reconstr Surg. 2016;138(3 Suppl):18S–28S. Sep.
   PubMed Web of Science ®Google Scholar
• Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7(6):442–452. Nov-Dec.
   PubMed Web of Science ®Google Scholar
• McCarty SM, Percival SL. Proteases and delayed wound healing. Adv Wound Care (New Rochelle). 2013;2(8):438–447. Oct.
   PubMedGoogle Scholar
• Xue M, Le NT, Jackson CJ. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets. 2006;10(1):143–155. Feb.
   PubMed Web of Science ®Google Scholar
• Wall IB, Moseley R, Baird DM, et al. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol. 2008;128(10):2526–2540. Oct.
   PubMed Web of Science ®Google Scholar
• Cook H, Davies KJ, Harding KG, et al. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000;115(2):225–233. Aug.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Menocal L, Salgado M, Ford D, et al. Stimulation of skin and wound fibroblast migration by mesenchymal stem cells derived from normal donors and chronic wound patients. Stem Cells Transl Med. 2012;1(3):221–229. Mar.
   PubMed Web of Science ®Google Scholar
• Stojadinovic O, Brem H, Vouthounis C, et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167(1):59–69. Jul.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim Y, Park J, et al. Recent advances in engineered stem cell-derived cell sheets for tissue regeneration. Polymers (Basel). 2019 Jan 26;11(2):209.
   Web of Science ®Google Scholar
• Ulrich D, Ulrich F, Unglaub F, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. J Plast Reconstr Aesthet Surg. 2010;63(6):1015–1021.
   PubMed Web of Science ®Google Scholar
• Xue M, Jackson CJ. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care (New Rochelle). 2015 Mar 1;4(3):119–136.
   PubMed Web of Science ®Google Scholar
• Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns. 2006;32(8):992–999. Dec.
   PubMed Web of Science ®Google Scholar
• Finnerty CC, Jeschke MG, Branski LK, et al. Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet. 2016 Oct 1;388(10052):1427–1436.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ding J, Tredget EE. The molecular basis of hypertrophic scars. Burns Trauma. 2016;4:2.
   PubMed Web of Science ®Google Scholar
• Lian N, Li T. Growth factor pathways in hypertrophic scars: molecular pathogenesis and therapeutic implications. Biomed Pharmacother. 2016;84:42–50.
   PubMed Web of Science ®Google Scholar
• Vågesjö E, Öhnstedt E, Mortier A, et al. Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria. Proc Nat Acad Sci (PNAS). 2018;115(8):1895–1900.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Soni K, Agrawal P, et al. Hypertrophic scars and keloids: a review and current treatment modalities. Biomed Dermatol. 2020;4(1):11.
   Google Scholar
• Huang C, Murphy GF, Akaishi S, et al. Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open. 2013;1(4):e25.
   PubMedGoogle Scholar
• Smith CJ, Smith JC, Finn MC. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil. 1987;8(2):126–131.
   PubMedGoogle Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835–870.
   PubMed Web of Science ®Google Scholar
• Kim HS, Sun X, Lee JH, et al. Advanced drug delivery systems and artificial skin grafts for skin wound healing. Adv Drug Deliv Rev. 2018 Dec 31.
   Google Scholar
• Rennert RC, Rodrigues M, Wong VW, et al. Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies. Expert Opin Biol Ther. 2013;13(11):1523–1541.
   PubMed Web of Science ®Google Scholar
• Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov. 2008;7(1):21–39.
   PubMed Web of Science ®Google Scholar
• Park JW, Hwang SR, Yoon IS. Advanced growth factor delivery systems in wound management and skin regeneration. Mol. 2017 Jul 27;22(8):1259.
   Web of Science ®Google Scholar
• Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 2014;22(5):569–578. Sep-Oct.
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601. Sep-Oct.
   PubMed Web of Science ®Google Scholar
• Dinh T, Braunagel S, Rosenblum BI. Growth factors in wound healing: the present and the future? Clin Podiatr Med Surg. 2015;32(1):109–119. Jan.
   PubMed Web of Science ®Google Scholar
• Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol. 1993;100(5):721–725. 1993/05/01/.
   PubMed Web of Science ®Google Scholar
• Pierce GF, Tarpley JE, Tseng J, et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest. 1995;96(3):1336–1350. Sep.
   PubMed Web of Science ®Google Scholar
• Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009;17(2):153–162. Mar-Apr.
   PubMed Web of Science ®Google Scholar
• Quatresooz P, Henry F, Paquet P, et al. Deciphering the impaired cytokine cascades in chronic leg ulcers (review). Int J Mol Med. 2003;11(4):411–418. Apr.
   PubMed Web of Science ®Google Scholar
• Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4(4):411–420. Oct.
   PubMedGoogle Scholar
• Cooper DM, Yu EZ, Hennessey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg. Jun 1994;219(6):688–691. discussion 91–2.
   PubMed Web of Science ®Google Scholar
• Cianfarani F, Tommasi R, Failla CM, et al. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol. 2006;154(1):34–41. Jan.
   PubMed Web of Science ®Google Scholar
• Berlanga-Acosta J, Fernandez-Montequin J, Valdes-Perez C, et al. Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome. Biomed Res Int. 2017;2017:2923759.
   PubMed Web of Science ®Google Scholar
• Gainza G, Villullas S, Pedraz JL, et al. Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration. Nanomed. 2015;11(6):1551–1573. Aug.
   PubMed Web of Science ®Google Scholar
• Brown GL, Nanney LB, Griffen J, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med. 1989 Jul 13;321(2):76–79.
   PubMed Web of Science ®Google Scholar
• Fang RC, Galiano RD. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics. 2008;2(1):1–12. Mar.
   PubMedGoogle Scholar
• Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. diabetic ulcer study group. J Vasc Surg. Jan 1995;21(1):71–78. discussion 79–81.
   PubMed Web of Science ®Google Scholar
• Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822–827. May.
   PubMed Web of Science ®Google Scholar
• Margolis DJ, Bartus C, Hoffstad O, et al. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen. 2005;13(6):531–536. Nov-Dec.
   PubMed Web of Science ®Google Scholar
• Fernandez-Montequin JI, Betancourt BY, Leyva-Gonzalez G, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. Int Wound J. 2009;6(1):67–72. Feb.
   PubMed Web of Science ®Google Scholar
• Akita S, Akino K, Imaizumi T, et al. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen. 2008;16(5):635–641. Sep-Oct.
   PubMed Web of Science ®Google Scholar
• Yao CC, Yao P, Wu H, et al. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor. Biomed Mater. 2006;1(1):33–37. Mar.
   PubMed Web of Science ®Google Scholar
• Tuyet HL, Nguyen Quynh TT, Vo Hoang Minh H, et al. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results. Int Wound J. 2009;6(2):159–166. Apr.
   PubMed Web of Science ®Google Scholar
• Kozynets HP, Osadcha OI, Boiars’ka HM, et al. [Determination of clinical efficacy of REGEN-D 150 preparation for local treatment of burns]. Klin Khir. 2011;7:65–68.
   PubMedGoogle Scholar
• Smiell JM. Clinical safety of becaplermin (rhPDGF-BB) gel. becaplermin studies group. Am J Surg. 1998;176(2A Suppl):68S–73S. Aug.
   PubMed Web of Science ®Google Scholar
• Boateng JS, Matthews KH, Stevens HN, et al. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97(8):2892–2923. Aug.
   PubMed Web of Science ®Google Scholar
• Boateng J, Catanzano O. advanced therapeutic dressings for effective wound healing–a review. J Pharm Sci. 2015;104(11):3653–3680. Nov.
   PubMed Web of Science ®Google Scholar
• Biondi M, Ungaro F, Quaglia F, et al. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev. 2008 Jan 14;60(2):229–242.
   PubMed Web of Science ®Google Scholar
• Fenton OS, Olafson KN, Pillai PS, et al. Advances in biomaterials for drug delivery. Adv Mater. 2018 May 7;30(29):1705328.
   PubMed Web of Science ®Google Scholar
• Quaglia F. Bioinspired tissue engineering: the great promise of protein delivery technologies. Int J Pharm. 2008 Dec 8;364(2):281–297.
   PubMed Web of Science ®Google Scholar
• Choi SM, Lee KM, Kim HJ, et al. Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice. Acta Biomater. 2018 Jan 15;66:325–334.
   PubMed Web of Science ®Google Scholar
• Lao G, Yan L, Yang C, et al. Controlled release of epidermal growth factor from hydrogels accelerates wound healing in diabetic rats. J Am Podiatr Med Assoc. 2012;102(2):89–98. Mar-Apr.
   PubMed Web of Science ®Google Scholar
• Lin YJ, Lee GH, Chou CW, et al. Stimulation of wound healing by PU/hydrogel composites containing fibroblast growth factor-2. J Mater Chem B. 2015;3(9):1931–1941.
   PubMed Web of Science ®Google Scholar
• Niiyama H, Kuroyanagi Y. Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative. J Artif Organs. 2014;17(1):81–87. Mar.
   PubMed Web of Science ®Google Scholar
• Schneider A, Wang XY, Kaplan DL, et al. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 2009;5(7):2570–2578. Sep.
   PubMed Web of Science ®Google Scholar
• Lord MS, Ellis AL, Farrugia BL, et al. Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing. J Control Release. 2017 Mar 28;250:48–61.
   PubMed Web of Science ®Google Scholar
• Gilmartin DJ, Soon A, Thrasivoulou C, et al. Sustained release of cx43 antisense oligodeoxynucleotides from coated collagen scaffolds promotes wound healing. Adv Healthc Mater. 2016;5(14):1786–1799.
   PubMed Web of Science ®Google Scholar
• Subbiah R, Guldberg RE. Materials science and design principles of growth factor delivery systems in tissue engineering and regenerative medicine. Adv Healthc Mater. 2019;8(1):1801000.
   PubMed Web of Science ®Google Scholar
• Barroso A, Mestre H, Ascenso A, et al. Nanomaterials in wound healing: from material sciences to wound healing applications. Nano Select. 2020;1(5):443–460.
   Google Scholar
• Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev. 2012 Apr 7;41(7):2545–2561.
   PubMed Web of Science ®Google Scholar
• Beckert S, Farrahi F, Aslam RS, et al. Lactate stimulates endothelial cell migration. Wound Repair Regen. 2006;14(3):321–324.
   PubMed Web of Science ®Google Scholar
• Trabold O, Wagner S, Wicke C, et al. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen. 2003;11(6):504–509.
   PubMed Web of Science ®Google Scholar
• Borselli C, Ungaro F, Oliviero O, et al. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A. 2010;92A(1):94–102.
   Web of Science ®Google Scholar
• Matica MA, Aachmann FL, Tondervik A, et al. Chitosan as a wound dressing starting material: antimicrobial properties and mode of action. Int J Mol Sci. 2019 Nov 24;20:23.
   Web of Science ®Google Scholar
• Desmet CM, Preat V, Gallez B. Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing. Adv Drug Deliv Rev. 2018;129:262–284.
   PubMed Web of Science ®Google Scholar
• Kalashnikova I, Das S, Seal S. Nanomaterials for wound healing: scope and advancement. Nanomed (Lond). 2015;10(16):2593–2612.
   PubMed Web of Science ®Google Scholar
• Vijayan A, James PP, Nanditha CK, et al. Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system. Int J Nanomed. 2019;14:2253–2263.
   PubMed Web of Science ®Google Scholar
• Yang DH, Seo DI, Lee D-W, et al. Preparation and evaluation of visible-light cured glycol chitosan hydrogel dressing containing dual growth factors for accelerated wound healing. J Ind Eng Chem. 2017;53::360–370.
   Web of Science ®Google Scholar
• Shimizu N, Ishida D, Yamamoto A, et al. Development of a functional wound dressing composed of hyaluronic acid spongy sheet containing bioactive components: evaluation of wound healing potential in animal tests. J Biomater Sci Polym Ed. 2014;25(12):1278–1291.
   PubMed Web of Science ®Google Scholar
• Choi JS, Yoo HS. Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties. J Biomed Mater Res A. 2010;95(2):564–573.
   PubMed Web of Science ®Google Scholar
• Beckert S, Haack S, Hierlemann H, et al. Stimulation of steroid-suppressed cutaneous healing by repeated topical application of IGF-I: different mechanisms of action based upon the mode of IGF-I delivery. J Surg Res. 2007 May 15;139(2):217–221.
   PubMed Web of Science ®Google Scholar
• Picheth GF, Sierakowski MR, Woehl MA, et al. Lysozyme-triggered epidermal growth factor release from bacterial cellulose membranes controlled by smart nanostructured films. J Pharm Sci. 2014;103(12):3958–3965.
   PubMed Web of Science ®Google Scholar
• Xuan X, Zhou Y, Chen A, et al. Silver crosslinked injectable bFGF-eluting supramolecular hydrogels speed up infected wound healing. J Mater Chem B. 2020 Feb 21;8(7):1359–1370.
   PubMed Web of Science ®Google Scholar
• Hong JP, Kim YW, Lee SK, et al. The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds. Ann Plast Surg. 2008;61(4):457–462.
   PubMed Web of Science ®Google Scholar
• Hajimiri M, Shahverdi S, Esfandiari MA, et al. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing. Drug Dev Ind Pharm. 2016 May 3;42(5):707–719.
   Web of Science ®Google Scholar
• Piran M, Vakilian S, Piran M, et al. In vitro fibroblast migration by sustained release of PDGF-BB loaded in chitosan nanoparticles incorporated in electrospun nanofibers for wound dressing applications. Artif Cells Nanomed Biotechnol. 2018;46(sup1):511–520.
   PubMed Web of Science ®Google Scholar
• Nejaddehbashi F, Hashemitabar M, Bayati V, et al. Application of polycaprolactone, chitosan, and collagen composite as a nanofibrous mat loaded with silver sulfadiazine and growth factors for wound dressing. Artif Organs. 2019;43(4):413–423.
   PubMed Web of Science ®Google Scholar
• Vijayan A, S A, Kumar GSV. PEG grafted chitosan scaffold for dual growth factor delivery for enhanced wound healing. Sci Rep. 2019 Dec 16;9(1):19165.
   PubMed Web of Science ®Google Scholar
• Sokolsky-Papkov M, Agashi K, Olaye A, et al. Polymer carriers for drug delivery in tissue engineering. Adv Drug Delliv Rev. 2007;59(4):187–206.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Nagate T, Matsuda H. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J Vet Med Sci. 2005;67(9):909–913.
   PubMed Web of Science ®Google Scholar
• Ulubayram K, Nur Cakar A, Korkusuz P, et al. EGF containing gelatin-based wound dressings. Biomaterials. 2001;22(11):1345–1356.
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Morimoto N, Ogino S, et al. Efficacy of gelatin gel sheets in sustaining the release of basic fibroblast growth factor for murine skin defects. J Surg Res. 2016;201(2):378–387.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang Z, Li Y, et al. Dual-crosslinked amorphous polysaccharide hydrogels based on chitosan/alginate for wound healing applications. Macromol Rapid Commun. 2018 May 31:e1800069.
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang H, Song T, et al. Sustainable dual release of antibiotic and growth factor from ph-responsive uniform alginate composite microparticles to enhance wound healing. ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22730–22744.
   PubMed Web of Science ®Google Scholar
• Ribeiro MP, Morgado PI, Miguel SP, et al. Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mater Sci Eng C Mater Biol Appl. 2013 Jul 1;33(5):2958–2966.
   PubMed Web of Science ®Google Scholar
• Pyun DG, Choi HJ, Yoon HS, et al. Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: synthesis, characterization, in vitro and in vivo studies. Colloids Surf B Biointerfaces. 2015 Nov 1;135:699–706.
   PubMed Web of Science ®Google Scholar
• Mohandas A, Anisha BS, Chennazhi KP, et al. Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds. Colloids Surf B Biointerfaces. 2015 Mar 1;127:105–113.
   PubMed Web of Science ®Google Scholar
• Kim H, Kong WH, Seong KY, et al. Hyaluronate-epidermal growth factor conjugate for skin wound healing and regeneration. Biomacromol. 2016 Nov 14;17(11):3694–3705.
   PubMed Web of Science ®Google Scholar
• Wang W, Lin S, Xiao Y, et al. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci. 2008 Jan 16;82(3–4):190–204.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu C, Wu Z, et al. A chitin film containing basic fibroblast growth factor with a chitin-binding domain as wound dressings. Carbohydr Polym. 2017 Oct 15;174:723–730.
   PubMed Web of Science ®Google Scholar
• Silva AKA, Richard C, Bessodes M, et al. Growth factor delivery approaches in hydrogels. Biomacromol. 2009;10(1):9–18.
   PubMed Web of Science ®Google Scholar
• He S, Shi D, Han Z, et al. Heparinized silk fibroin hydrogels loading FGF1 promote the wound healing in rats with full-thickness skin excision. Biomed Eng Online. 2019 Oct 2;18(1):97.
   PubMed Web of Science ®Google Scholar
• Etxabide A, Vairo C, Santos-Vizcaino E, et al. Ultra thin hydro-films based on lactose-crosslinked fish gelatin for wound healing applications. Int J Pharm. 2017 Sep 15;530(1–2):455–467.
   PubMed Web of Science ®Google Scholar
• Oh JS, Lee EJ. Engineered dressing of hybrid chitosan-silica for effective delivery of keratin growth factor and acceleration of wound healing. Mater Sci Eng C Mater Biol Appl. 2019;103:109815.
   PubMed Web of Science ®Google Scholar
• Niu Y, Li Q, Ding Y, et al. Engineered delivery strategies for enhanced control of growth factor activities in wound healing. Adv Drug Deliv Rev. 2019;146:190–208.
   PubMed Web of Science ®Google Scholar
• Xie Z, Paras CB, Weng H, et al. Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomater. 2013;9(12):9351–9359.
   PubMed Web of Science ®Google Scholar
• Wu J, Ye J, Zhu J, et al. Heparin-based coacervate of FGF2 improves dermal regeneration by asserting a synergistic role with cell proliferation and endogenous facilitated VEGF for cutaneous wound healing. Biomacromol. 2016 Jun 13;17(6):2168–2177.
   PubMed Web of Science ®Google Scholar
• Liao AH, Hung CR, Chen HK, et al. Ultrasound-mediated EGF-coated-microbubble cavitation in dressings for wound-healing applications. Sci Rep. 2018 May 29;8(1):8327.
   PubMed Web of Science ®Google Scholar
• Li X, Ye X, Qi J, et al. EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent. Int J Nanomed. 2016;11:3993–4009.
   PubMed Web of Science ®Google Scholar
• Lin X, Guan X, Wu Y, et al. An alginate/poly(N-isopropylacrylamide)-based composite hydrogel dressing with stepwise delivery of drug and growth factor for wound repair. Mater Sci Eng C. 2020/10/01/ 2020;115: 111123.
   PubMed Web of Science ®Google Scholar
• Jazwa A, Kucharzewska P, Leja J, et al. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Genet Vaccines Ther. 2010;8:6.
   PubMedGoogle Scholar
• Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nat. 2000 Sep 14;407(6801):242–248.
   Web of Science ®Google Scholar
• Choi DH, Subbiah R, Kim IH, et al. Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis. Small. 2013;9(20):3468–3476.
   PubMed Web of Science ®Google Scholar
• Losi P, Briganti E, Errico C, et al. Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. Acta Biomater. 2013;9(8):7814–7821.
   PubMed Web of Science ®Google Scholar
• Gizaw M, Thompson J, Faglie A, et al. Electrospun fibers as a dressing material for drug and biological agent delivery in wound healing applications. Bioeng (Basel). 2018 Jan 27;5:1.
   Google Scholar
• Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine. 2013;8:2997–3017.
   PubMed Web of Science ®Google Scholar
• Miguel SP, Sequeira RS, Moreira AF, et al. An overview of electrospun membranes loaded with bioactive molecules for improving the wound healing process. Eur J Pharm Biopharm. Jun 2019;139:1–22.
   PubMed Web of Science ®Google Scholar
• Meinel AJ, Germershaus O, Luhmann T, et al. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm. 2012;81(1):1–13.
   PubMed Web of Science ®Google Scholar
• Son YJ, Kim WJ, Yoo HS. Therapeutic applications of electrospun nanofibers for drug delivery systems. Arch Pharm Res. 2014;37(1):69–78.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu B, Carlson MA, et al. Recent advances in electrospun nanofibers for wound healing. Nanomed (Lond). 2017;12(11):1335–1352.
   PubMed Web of Science ®Google Scholar
• Liu M, Duan XP, Li YM, et al. Electrospun nanofibers for wound healing. Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:1413–1423. doi: 10.1016/j.msec.2017.03.034.
   PubMed Web of Science ®Google Scholar
• Sebe I, Szabo P, Kallai-Szabo B, et al. Incorporating small molecules or biologics into nanofibers for optimized drug release: A review. Int J Pharm. 2015 Oct 15;494(1):516–530.
   PubMed Web of Science ®Google Scholar
• Choi JS, Leong KW, Yoo HS. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials. 2008;29(5):587–596.
   PubMed Web of Science ®Google Scholar
• Dwivedi C, Pandey I, Pandey H, et al. In vivo diabetic wound healing with nanofibrous scaffolds modified with gentamicin and recombinant human epidermal growth factor. J Biomed Mater Res A. 2018;106(3):641–651.
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang L, Zhu K. Coaxial electrospinning for encapsulation and controlled release of fragile water-soluble bioactive agents. J Control Release. 2014 Nov 10;193:296–303.
   PubMed Web of Science ®Google Scholar
• Ji W, Yang F, van den Beucken JJ, et al. Fibrous scaffolds loaded with protein prepared by blend or coaxial electrospinning. Acta Biomater. 2010;6(11):4199–4207.
   PubMed Web of Science ®Google Scholar
• Choi JS, Choi SH, Yoo HS. Coaxial electrospun nanofibers for treatment of diabetic ulcers with binary release of multiple growth factors. J Mater Chem. 2011;21(14):5258–5267.
   Web of Science ®Google Scholar
• Lai HJ, Kuan CH, Wu HC, et al. Tailored design of electrospun composite nanofibers with staged release of multiple angiogenic growth factors for chronic wound healing. Acta Biomater. 2014;10(10):4156–4166.
   PubMed Web of Science ®Google Scholar
• McClellan P, Landis WJ. Recent applications of coaxial and emulsion electrospinning methods in the field of tissue engineering. Biores Open Access. 2016;5(1):212–227.
   PubMed Web of Science ®Google Scholar
• Zhang C, Feng F, Zhang H. Emulsion electrospinning: fundamentals, food applications and prospects. Trends Food Sci Tech. 2018;80:175–186.
   Web of Science ®Google Scholar
• Yang Y, Xia T, Zhi W, et al. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. Biomaterials. 2011;32(18):4243–4254.
   PubMed Web of Science ®Google Scholar
• Garcia-Orue I, Gainza G, Gutierrez FB, et al. Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications. Int J Pharm. 2017 May 25;523(2):556–566.
   PubMed Web of Science ®Google Scholar
• Norouzi M, Shabani I, Ahvaz HH, et al. PLGA/gelatin hybrid nanofibrous scaffolds encapsulating EGF for skin regeneration. J Biomed Mater Res A. 2014 Oct 24;103(7);2225-2235.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qian Y, Li L, et al. Evaluation of emulsion electrospun polycaprolactone/hyaluronan/epidermal growth factor nanofibrous scaffolds for wound healing. J Biomater Appl. 2016;30(6):686–698.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Lu WW, Wang M. Modulating the release of vascular endothelial growth factor by negative-voltage emulsion electrospinning for improved vascular regeneration. Mater Lett. 2017;193:1–4.
   Web of Science ®Google Scholar
• Mouthuy PA, Groszkowski L, Ye H. Performances of a portable electrospinning apparatus. Biotechnol Lett. 2015;37(5):1107–1116.
   PubMed Web of Science ®Google Scholar
• Xu SC, Qin CC, Yu M, et al. A battery-operated portable handheld electrospinning apparatus. Nanoscale. 2015 Aug 7;7(29):12351–12355.
   PubMed Web of Science ®Google Scholar
• Yan X, Yu M, Zhang LH, et al. A portable electrospinning apparatus based on a small solar cell and a hand generator: design, performance and application. Nanoscale. 2016 Jan 7;8(1):209–213.
   PubMed Web of Science ®Google Scholar
• Brown TD, Dalton PD, Hutmacher DW. Direct writing by way of melt electrospinning. Adv Mater. 2011 Dec 15;23(47):5651–5657.
   PubMed Web of Science ®Google Scholar
• Ristovski N, Bock N, Liao S, et al. Improved fabrication of melt electrospun tissue engineering scaffolds using direct writing and advanced electric field control. Biointerphases. 2015 Mar 25;10(1):011006.
   PubMed Web of Science ®Google Scholar
• Kim G, Son J, Su A P, et al. Hybrid process for fabricating 3d hierarchical scaffolds combining rapid prototyping and electrospinning. Macromol Rapid Commun. 2008;29(19):1577–1581.
   Web of Science ®Google Scholar
• Ross R, Glomset J, Kariya B, et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974;71(4):1207–1210.
   PubMed Web of Science ®Google Scholar
• Mazzucco L, Borzini P, Gope R. Platelet-derived factors involved in tissue repair-from signal to function. Transfus Med Rev. 2010;24(3):218–234.
   PubMed Web of Science ®Google Scholar
• Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;18(1):27–33.
   PubMedGoogle Scholar
• Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–2272.
   PubMed Web of Science ®Google Scholar
• Saucedo JM, Yaffe MA, Berschback JC, et al. Platelet-rich plasma. J Hand Surg Am. Mar 2012;37(3):587–589.
   PubMed Web of Science ®Google Scholar
• Chicharro-Alcantara D, Rubio-Zaragoza M, Damia-Gimenez E, et al. Platelet rich plasma: new insights for cutaneous wound healing management. J Funct Biomater. 2018 Jan 18;9:1.
   Web of Science ®Google Scholar
• Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502–1508.
   PubMed Web of Science ®Google Scholar
• Roukis TS, Zgonis T, Tiernan B. Autologous platelet-rich plasma for wound and osseous healing: a review of the literature and commercially available products. Adv Ther. 2006;23(2):218–237.
   PubMed Web of Science ®Google Scholar
• Bir SC, Esaki J, Marui A, et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. J Vasc Surg. 2009;50(4):870–79 e2.
   PubMed Web of Science ®Google Scholar
• Mendes BB, Gomez-Florit M, Babo PS, et al. Blood derivatives awaken in regenerative medicine strategies to modulate wound healing. Adv Drug Deliv Rev. 2018;129:376–393.
   PubMed Web of Science ®Google Scholar
• Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–496.
   PubMed Web of Science ®Google Scholar
• Naik B, Karunakar P, Jayadev M, et al. Role of platelet rich fibrin in wound healing: A critical review. J Conserv Dent. 2013;16(4):284–293.
   PubMedGoogle Scholar
• Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care. 2008;21(12):568–575.
   PubMedGoogle Scholar
• Tsai HC, Lehman CW, Chen CM. Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J Wound Care. 2019 Jan 2;28(1):15–21.
   PubMed Web of Science ®Google Scholar
• Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012 Feb 15;94(4):308–316.
   PubMed Web of Science ®Google Scholar
• Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–364.
   PubMed Web of Science ®Google Scholar
• Sam G, Vadakkekuttical RJ, Amol NV. In vitro evaluation of mechanical properties of platelet-rich fibrin membrane and scanning electron microscopic examination of its surface characteristics. J Indian Soc Periodontol. 2015;19(1):32–36. Jan-Feb.
   PubMedGoogle Scholar
• Qiu M, Chen D, Shen C, et al. Platelet-Rich Plasma-Loaded Poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) hydrogel dressing promotes full-thickness skin wound healing in a rodent model. Int J Mol Sci. 2016 Jun 24;17(7):1001.
   Web of Science ®Google Scholar
• Mohammadi R, Mehrtash M, Mehrtash M, et al. Effect of platelet rich plasma combined with chitosan biodegradable film on full-thickness wound healing in rat model. Bull Emerg Trauma. 2016;4(1):29–37.
   PubMedGoogle Scholar
• Kim W, Jang CH, Kim G. Optimally designed collagen/polycaprolactone biocomposites supplemented with controlled release of HA/TCP/rhBMP-2 and HA/TCP/PRP for hard tissue regeneration. Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:763–772.
   PubMed Web of Science ®Google Scholar
• Liu J, Nie H, Xu Z, et al. Construction of PRP-containing nanofibrous scaffolds for controlled release and their application to cartilage regeneration. J Mater Chem B. 2015;3(4):581–591.
   PubMed Web of Science ®Google Scholar
• Lei X, Yang Y, Shan G, et al. Preparation of ADM/PRP freeze-dried dressing and effect of mice full-thickness skin defect model. Biomed Mater. 2019 Mar 7;14(3):035004.
   PubMed Web of Science ®Google Scholar
• Liu X, Yang Y, Niu X, et al. An in situ photocrosslinkable platelet rich plasma - complexed hydrogel glue with growth factor controlled release ability to promote cartilage defect repair. Acta Biomater. 2017 Oct 15;62:179–187.
   Google Scholar
• Notodihardjo PV, Morimoto N, Kakudo N, et al. Gelatin hydrogel impregnated with platelet-rich plasma releasate promotes angiogenesis and wound healing in murine model. J Artif Organs. 2014 Oct 18;18(1);64-71.
   PubMed Web of Science ®Google Scholar
• Toffler M, Toscano N, Holtzclaw D, et al. Introducing Choukroun’s platelet rich fibrin (PRF) to the reconstructive surgery milieu. J Implant Adv Clin Dent. 2009;1(6):21–30.
   Google Scholar
• Suzuki S, Morimoto N, Ikada Y. Gelatin gel as a carrier of platelet-derived growth factors. J Biomater Appl. 2013;28(4):595–606.
   PubMed Web of Science ®Google Scholar
• Sun H, Lv H, Qiu F, et al. Clinical application of a 3D-printed scaffold in chronic wound treatment: a case series. J Wound Care. 2018 May 2;27(5):262–271.
   PubMed Web of Science ®Google Scholar
• Barsotti MC, Losi P, Briganti E, et al. Effect of platelet lysate on human cells involved in different phases of wound healing. PLoS One. 2013;8(12):e84753.
   PubMed Web of Science ®Google Scholar
• Ranzato E, Patrone M, Mazzucco L, et al. Platelet lysate stimulates wound repair of HaCaT keratinocytes. Br J Dermatol. 2008;159(3):537–545.
   PubMed Web of Science ®Google Scholar
• Rossi S, Faccendini A, Bonferoni MC, et al. “Sponge-like” dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Int J Pharm. 2013 Jan 20;440(2):207–215.
   PubMed Web of Science ®Google Scholar
• Mori M, Rossi S, Ferrari F, et al. Sponge-like dressings based on the association of chitosan and sericin for the treatment of chronic skin ulcers. ii. loading of the hemoderivative platelet lysate. J Pharm Sci. 2016;105(3):1188–1195.
   PubMed Web of Science ®Google Scholar
• Nardini M, Perteghella S, Mastracci L, et al. Growth factors delivery system for skin regeneration: an advanced wound dressing. Pharmaceutics. 2020 Feb 3;12:2.
   Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Rossi S, et al. Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions. J Pharm Pharmacol. 2011;63(2):189–198.
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Rossi S, et al. Platelet lysate and chondroitin sulfate loaded contact lenses to heal corneal lesions. Int J Pharm. 2016 Jul 25;509(1–2):188–196.
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Rossi S, et al. Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers. Int J Pharm. 2012 Apr 15;426(1–2):1–6.
   PubMed Web of Science ®Google Scholar
• Mori M, Rossi S, Bonferoni MC, et al. Calcium alginate particles for the combined delivery of platelet lysate and vancomycin hydrochloride in chronic skin ulcers. Int J Pharm. 2014 Jan 30;461(1–2):505–513.
   PubMed Web of Science ®Google Scholar
• Rossi S, Mori M, Vigani B, et al. A novel dressing for the combined delivery of platelet lysate and vancomycin hydrochloride to chronic skin ulcers: hyaluronic acid particles in alginate matrices. Eur J Pharm Sci. 2018 Jun 15;118:87–95.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Rossi S, et al. Association of alpha tocopherol and Ag sulfadiazine chitosan oleate nanocarriers in bioactive dressings supporting platelet lysate application to skin wounds. Mar Drugs. 2018 Feb 9;16:2.
   Web of Science ®Google Scholar
• Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006;4(5):932–939.
   PubMed Web of Science ®Google Scholar
• Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem. 2017;82:405–456.
   PubMedGoogle Scholar
• Heher P, Muhleder S, Mittermayr R, et al. Fibrin-based delivery strategies for acute and chronic wound healing. Adv Drug Deliv Rev. 2018;129:134–147.
   PubMed Web of Science ®Google Scholar
• Rajangam T, An SS. Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int J Nanomed. 2013;8:3641–3662.
   PubMed Web of Science ®Google Scholar
• Whelan D, Caplice NM, Clover AJ. Fibrin as a delivery system in wound healing tissue engineering applications. J Control Release. 2014 Dec 28;196:1–8.
   PubMed Web of Science ®Google Scholar
• Drinnan CT, Zhang G, Alexander MA, et al. Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J Control Release. 2010 Oct 15;147(2):180–186.
   PubMed Web of Science ®Google Scholar
• Ehrbar M, Djonov VG, Schnell C, et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30;94(8):1124–1132.
   PubMed Web of Science ®Google Scholar
• Martino MM, Hubbell JA. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. Faseb J. 2010;24(12):4711–4721.
   PubMed Web of Science ®Google Scholar
• Pandit AS, Feldman DS, Caulfield J, et al. Stimulation of angiogenesis by FGF-1 delivered through a modified fibrin scaffold. Growth Factors. 1998;15(2):113–123.
   PubMed Web of Science ®Google Scholar
• Geer DJ, Swartz DD, Andreadis ST. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol. 2005;167(6):1575–1586.
   PubMed Web of Science ®Google Scholar
• Muhamed I, Sproul EP, Ligler FS, et al. Fibrin nanoparticles coupled with keratinocyte growth factor enhance the dermal wound-healing rate. ACS Appl Mater Interfaces. 2019 Jan 30;11(4):3771–3780.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhao M, Zhao Y, et al. A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies. J Mater Sci Mater Med. 2011;22(5):1221–1230.
   PubMed Web of Science ®Google Scholar
• Wong C, Inman E, Spaethe R, et al. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost. 2003;89(3):573–582.
   PubMed Web of Science ®Google Scholar
• Briganti E, Spiller D, Mirtelli C, et al. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J Control Release. 2010 Feb 25;142(1):14–21.
   PubMed Web of Science ®Google Scholar
• Layman H, Li X, Nagar E, et al. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. J Biomater Sci Polym Ed. 2012;23(1–4):185–206.
   PubMed Web of Science ®Google Scholar
• Layman H, Rahnemai-Azar AA, Pham SM, et al. Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia. Tissue Eng Part A. 2011;17(1–2):243–254.
   PubMed Web of Science ®Google Scholar
• Mogford JE, Tawil B, Jia S, et al. Fibrin sealant combined with fibroblasts and platelet-derived growth factor enhance wound healing in excisional wounds. Wound Repair Regen. 2009;17(3):405–410.
   PubMed Web of Science ®Google Scholar
• Gwak SJ, Kim SS, Sung K, et al. Synergistic effect of keratinocyte transplantation and epidermal growth factor delivery on epidermal regeneration. Cell Transplant. 2005;14(10):809–817.
   PubMed Web of Science ®Google Scholar